Article ID Journal Published Year Pages File Type
8449418 European Journal of Cancer Supplements 2007 4 Pages PDF
Abstract
Until existing or new technologies provide utility for alternative sampling, access to human tissue samples of consistent quality will underpin the success of cancer drug pipelines in the era of molecular biological biomarkers and personalised medicine.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Tissue collection in drug discovery and development research
Authors
, ,